HOME

CANCER TYPES 

TREATMENTS

PREVENTION

SCREENING

FORUM

LINKS 

LANGUAGE

ABOUT US

CONTACT

 

 

  Common
  Cancer Types


  Bladder Cancer


  Breast Cancer


  Colon Cancer


  Rectal Cancer


  Endometrial Cancer


  Kidney Cancer


  Leukemia


  Lung Cancer


  Melanoma


  Non-Hodgkin's


  Pancreatic Cancer


  Prostate Cancer


  Skin Cancer


  Thyroid Cancer


 

 

  All Cancer Types


  A to Z List of Cancers


  Childhood Cancers


  Women's Cancers


 

 

 


Español

 


 

 

 

       

 


Childhood Medulloblastoma  

 

/ Treatment /

Childhood medulloblastoma is a disease in which benign (noncancer) or malignant (cancer) cells form in the tissues of the brain.

Childhood medulloblastoma (tumor) usually forms in the cerebellum, which is at the lower back of the brain. The cerebellum is the part of the brain that controls movement, balance, and posture. Childhood medulloblastoma may also be called primitive neuroectodermal tumor (PNET).

About 1 out of 5 childhood brain tumors are medulloblastomas. Although cancer is rare in children, brain tumors are the most common type of childhood cancer other than leukemia and lymphoma.

This summary refers to the treatment of primary brain tumors (tumors that begin in the brain). Treatment for metastatic brain tumors, which are tumors formed by cancer cells that begin in other parts of the body and spread to the brain, is not discussed in this summary.

Brain tumors can occur in both children and adults; however, treatment for children may be different than treatment for adults.

The cause of most childhood brain tumors is unknown.

The signs of childhood medulloblastoma vary and often depend on the child’s age and where the tumor is located.

These symptoms may be caused by a medulloblastoma or other conditions. A doctor should be consulted if any of the following problems occur:

  • Loss of balance, difficulty walking, worsening handwriting, or slow speech.

  • Morning headache or headache that goes away after vomiting.

  • Nausea and vomiting.

  • Unusual sleepiness or change in energy level.

  • Change in personality or behavior.

  • Unexplained weight loss or weight gain.

Tests that examine the brain and spinal cord are used to detect (find) childhood medulloblastoma.

The following tests and procedures may be used:

  • CT scan (CAT scan): A procedure that makes a series of detailed pictures of areas inside the body, taken from different angles. The pictures are made by a computer linked to an x-ray machine. A dye may be injected into a vein or swallowed to help the organs or tissues show up more clearly. This procedure is also called computed tomography, computerized tomography, or computerized axial tomography.

  • MRI (magnetic resonance imaging): A procedure that uses a magnet, radio waves, and a computer to make a series of detailed pictures of areas inside the brain and spinal cord. A substance called gadolinium is injected into the patient through a vein. The gadolinium collects around the cancer cells so they show up brighter in the picture. This procedure is also called nuclear magnetic resonance imaging (NMRI).

Childhood medulloblastoma is diagnosed and removed in surgery.

If a brain tumor is suspected, a biopsy is done by removing part of the skull and using a needle to remove a sample of the tumor tissue. A pathologist views the tissue under a microscope to look for cancer cells. If cancer cells are found, the doctor will remove as much tumor as possible during the same surgery.

Certain factors affect prognosis (chance of recovery) and treatment options.

The prognosis (chance of recovery) and treatment options depend on:

  • The age of the child when the tumor is found.

  • The location of the tumor.

  • The amount of tumor remaining after surgery.

  • Whether the cancer has spread to other parts of the central nervous system (brain and spinal cord), or to other parts of the body, such as the bones.

/ Treatment /

 
 
 

<< All Cancer Types

 

 

 

 

 

    Privacy policy   Legal   Terms of Use

All information is taken from: National Cancer Institute, NCI